Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, which has recently been mentioned as an independent cardiovascular risk factor. OBJECTIVES: Endocan is a novel molecule of endothelial dysfunction. We aimed to evaluate the associations of serum en...

Descripción completa

Detalles Bibliográficos
Autores principales: Erman, Hande, Beydogan, Engin, Cetin, Seher Irem, Boyuk, Banu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152978/
https://www.ncbi.nlm.nih.gov/pubmed/32317862
http://dx.doi.org/10.1155/2020/3534042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152978/
https://www.ncbi.nlm.nih.gov/pubmed/32317862
http://dx.doi.org/10.1155/2020/3534042

Ejemplares similares